NICE guideline NG87: ADHD diagnosis and management

Tier 1: Established: peer-reviewed research or government health authority
Publisher: National Institute for Health and Care Excellence (NICE) · Published: August 8, 2026 · Accessed: August 8, 2026

Visit the source ↗

Claims this source supports

• NICE NG87 covers recognising, diagnosing and managing ADHD in children, young people and adults, aiming to improve recognition and diagnosis and the quality of care and support.
• The guideline includes recommendations on recognition and referral, information and support, managing ADHD, medication (including monitoring and review), adherence to treatment, service organisation and training, and diagnosis.
• The guideline applies to healthcare professionals, commissioners and providers, and people with ADHD and their families and carers.
• NG87 updates and replaces NICE guideline CG72 (September 2008) and NICE technology appraisal guidance 98 (2006).